NCT01286441.

Study name	A Randomized, Double‐blind, Parallel‐group, Multicenter, Vehicle‐controlled Phase 2 Dose‐Ranging Trial of the Safety and Efficacy of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Methods	The primary objective of this study is to evaluate the efficacy and safety of 10%, 20%, and 30% East Indian Sandalwood Oil (EISO) ointment compared with the ointment placebo administered twice daily (bid) for 12 weeks for the treatment of common warts (verruca vulgaris).
Participants	Inclusion criteria of the trial Male or female 18 years of age or older at enrolment
Interventions	East Indian Sandalwood Oil (EISO) ointment compared with the ointment placebo administered twice daily (bid) for 12 weeks
Outcomes	Outcomes of the trial Efficacy and safety Complete resolution (Clinical evaluations, including wart counts, wart measurements, and recording of adverse events and concomitant medications, will be performed. Photographs of the treatment area will be taken at all study visits.) Recurrence of common warts and to obtain an estimate of systemic exposure to alpha‐santalol at steady state
Starting date	May 2011
Contact information	Howard L Sofen, MD, Principal Investigator
Notes	This trial is not yet recruiting.